Firms Should Opt For Qui Tam Settlements To Avoid Medicare Boot - Attorney
This article was originally published in The Gray Sheet
Executive Summary
OrthoLogic's $650,000 settlement of a False Claims Act civil case with the Justice Department does not bar the company from participating in Medicare or any federal health care program.
You may also be interested in...
OrthoLogic
Divestiture of the firm's continuous passive motion (CPM) orthopedic rehabilitation device business to OrthoRehab, Inc., is outlined in a definitive agreement announced May 9. Terms of the deal are not being disclosed, but OrthoLogic expects total consideration of $15-18 mil. Plans to seek a buyer for the business were first announced in January (1"The Gray Sheet" Jan. 29, 2001, p. 14). OrthoLogic plans to refocus on devices for fracture healing and spinal repair. A loss of $3-5 mil. will be recorded on the sale of the business assets upon closing, expected in June, and an additional one-time charge of $7-10 mil. will cover other costs associated with the divestiture
LifeScan Defective SureStep Glucose Meter Civil Trial Slated For September
Johnson & Johnson subsidiary LifeScan will remain on probation for a three-year period, during which FDA and the U.S. Probation Office will oversee the firm's documentation of medical device reporting (MDR) complaints.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.